Monoamine oxidase inhibition by moclobemide and 2-Aminoethyl carboxamide derivatives: mode of action and kinetic characteristics
The selective, reversible inhibitors of monoamine oxidase (MAO) moclobemide and Ro 41-1049 (selective for MAO-A), as well as of Ro 16-6491 and Ro 19-6327 (selective for MAO-B) inhibited the enzyme with an initial competitive phase, followed by a time-dependent inhibition of MAO. Ro 41-1049, Ro 16-6491 and Ro 19-6327, being activated by MAO into reversible adducts, fit into the classification as mechanism-based inhibitors. Conversely, since no product formation was observed after incubation of tissue homogenates with moclobemide, this drug probably belongs to the class of the “slow-binding” MAO inhibitors.
KeywordsMonoamine Oxidase Human Platelet Carboxamide Derivative Deuterated Derivative Human Platelet Membrane
Unable to display preview. Download preview PDF.
- Da Prada M, Kettler R, Keller HH, Cesura AM, Richards JG, Saura Marti J, Muggli-Maniglio D, Wyss P-C, Kyburz E, Imhof R (1990) From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors. J Neural Transm [Suppl] 29:279–292.Google Scholar
- Williams JW, Morrison JF (1979) The kinetic of reversible tight-binding inhibition. Meth Enzymol 63:337–467.Google Scholar